Nature

Effects of open-label placebos across populations and outcomes: an updated systematic review and meta-analysis of randomized controlled trials

The placebo effect is a well-known psychological phenomenon that can lead to significant improvements in both clinical and non-clinical populations for self-report outcomes (e.g., self-rated ...
Nasdaq

Satellos Announces Encouraging Functional Data from the 28-day Phase 1b Open-Label Trial of SAT-3247 in Adults with Duchenne Muscular Dystrophy

Phase 1b data shows treatment with SAT-3247 was safe and well-tolerated Pharmacokinetic (PK) profile of SAT-3247 translated as expected to Duchenne Muscular Dystrophy (DMD) patients taking concurrent ...
Nature

A single-center, single-arm, prospective, open-label, and comparative trial to evaluate the safety and tolerability profile of a 90-day oral L-arginine hydrochloride ...

Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative disorder for which there is no effective cure. Moreover, malnutrition significantly impacts the prognosis and overall ...
Nasdaq

Cassava Sciences Announces Expansion of Open-Label Extension Trials

Ongoing open-label extension trials of simufilam in Alzheimer’s disease to be extended by up to an additional 36 months. The extension provides participants the opportunity to continue on treatment, ...